In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 issued for its implementation, as amended and supplemented, the Competition Council makes available to the public the \u201coperation summary\u201d below, containing the information provided by the parties.<\/p>\n
This information has been prepared by the notifying parties, who are solely responsible. Any inaccurate or distorted information contained therein does not in any way prejudge the Competition Council’s position on the proposed operation.<\/p>\n
The publication of this press release does not attest to the completeness of the file provided for in Article 9 of Decree No. 2-14-652 issued for the implementation of Law No. 104-12 on freedom of prices and competition, as amended and supplemented.<\/p>\n
Names of the companies and groups concerned:<\/strong><\/p>\n Nature of the operation<\/strong><\/p>\n Economic sectors concerned<\/strong><\/p>\n Deadline for interested third parties to submit their observations<\/strong><\/p>\n NON-CONFIDENTIAL SUMMARY OF THE OPERATION PROVIDED BY THE PARTIES<\/strong><\/p>\n The Competition Council received notification of an economic concentration operation concerning the acquisition by the company DS Investments of 100% of the capital and voting rights of Pharmena, active in the sector of dietary supplements distribution.<\/p>\n \u201cDS Investments S\u00e0rl\u201d is a Luxembourg company whose purpose is to acquire stakes, in Luxembourg or abroad, in all companies, and to manage these stakes.<\/p>\n \u201cPharmena S\u00e0rl\u201d is a Moroccan company, specialized in the sector of dietary supplements distribution.<\/p>\n <\/p>\n Done in Rabat, on September 5, 2024.<\/p>\n","protected":false},"excerpt":{"rendered":" In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 issued for its implementation, as amended and supplemented, the Competition Council makes available to the public the \u201coperation summary\u201d below, containing the information provided by the parties. This information has been prepared by the notifying parties, who are solely responsible. Any inaccurate or distorted information contained therein does not in any way prejudge the Competition Council’s position on the proposed operation. The publication of this press release does not attest to the completeness of the file provided for in Article 9 of Decree No. 2-14-652 issued for the implementation of Law No. 104-12 on freedom of prices and competition, as amended and supplemented. Names of the companies and groups concerned: The acquirer: The company \u201cDS Investments S\u00e0rl\u201d; The target: The company \u201cPharmena S\u00e0rl\u201d. Nature of the operation Takeover Economic sectors concerned The market for the distribution of dietary supplements. Deadline for interested third parties to submit their observations 10 days from the date of publication of this press release, i.e. September 16, 2024. NON-CONFIDENTIAL SUMMARY OF THE OPERATION PROVIDED BY THE PARTIES The Competition Council received notification of an economic concentration operation concerning the acquisition by the company DS Investments of 100% of the capital and voting rights of Pharmena, active in the sector of dietary supplements distribution. \u201cDS Investments S\u00e0rl\u201d is a Luxembourg company whose purpose is to acquire stakes, in Luxembourg or abroad, in all companies, and to manage these stakes. \u201cPharmena S\u00e0rl\u201d is a Moroccan company, specialized in the sector of dietary supplements distribution. Done in Rabat, on September 5, 2024.<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[352],"tags":[],"class_list":["post-40783","post","type-post","status-publish","format-standard","hentry","category-press-releases"],"acf":[],"yoast_head":"\n\n
\n
\n
\n